AMRX
Amneal Pharmaceuticals Inc
Halal Rating :
Last Price
$8.26
Last updated:
Market Cap
-
7D Change
6.93%
1 Year Change
50.91%
Company Overview
Industries
Exchange
Next Earnings Date
Amneal Pharmaceuticals Inc is a global pharmaceutical company that develops, licenses, manufactures, markets and distributes generic and specialty pharmaceutical products. The company focuses on developing complex generics, specialty branded products, and biosimilars across a broad range of therapeutic areas.
Use of Interest
| Reporting Date | Total Revenue | Total Operating Expense | Interest Income | Interest Expense | Interest Income Ratio | Interest Expense Ratio |
|---|---|---|---|---|---|---|
| Sept. 30, 2024 | $702.47m | $613.66m | - | - | 0.00% | 0.00% |
| June 30, 2024 | $701.78m | $606.31m | - | - | 0.00% | 0.00% |
| March 31, 2024 | $659.19m | $669.94m | - | - | 0.00% | 0.00% |
Company Impact
Help us evaluate Amneal Pharmaceuticals Inc's impact from a halal perspective. Vote on the most significant aspect and submit any considerations that we may have missed.